Inventor
SAITO DAISUKE ROLAND
US36 patents
⚠️ This page may combine multiple inventors who share the name “SAITO DAISUKE ROLAND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE INC
11 patentsUS7622508B2Nov 24, 2009
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE INC39 citations94
US7994209B2Aug 9, 2011
3-phenoxymethylpyrrolidine compounds
THERAVANCE INC14 citations92
US7902220B2Mar 8, 2011
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
THERAVANCE INC14 citations92
US7888386B2Feb 15, 2011
3-(phenoxyphenylmethyl)pyrrolidine compounds
THERAVANCE INC30 citations92
US7947710B2May 24, 2011
Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE INC9 citations84
US7691878B2Apr 6, 2010
Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE INC13 citations84
US7399863B2Jul 15, 2008
Amino-substituted ethylamino β2 adrenergic receptor agonists
THERAVANCE INC12 citations84
US7902221B2Mar 8, 2011
Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE INC10 citations82
US8383669B2Feb 26, 2013
Crystalline form of a 3-phenoxymethylpyrrolidine compound
THERAVANCE INC4 citations74
US7994165B2Aug 9, 2011
Aryl aniline derivatives as β2 adrenergic receptor agonists
THERAVANCE INC0 citations52
US7964730B2Jun 21, 2011
Amino-substituted ethylamino β2 adrenergic receptor agonists
THERAVANCE INC0 citations52
STANGELAND ERIC L
8 patentsUS8242164B2Aug 14, 2012
3-(phenoxyphenylmethyl)pyrrolidine compounds
STANGELAND ERIC L9 citations84
US8471040B2Jun 25, 2013
Serotonin reuptake inhibitors
STANGELAND ERIC L3 citations63
US9000191B2Apr 7, 2015
Serotonin reuptake inhibitors
STANGELAND ERIC L0 citations52
US8933249B2Jan 13, 2015
3-(phenoxyphenylmethyl)pyrrolidine compounds
STANGELAND ERIC L0 citations52
US8853255B2Oct 7, 2014
3-phenoxymethylpyrrolidine compounds
STANGELAND ERIC L0 citations52
US8729119B2May 20, 2014
Serotonin reuptake inhibitors
STANGELAND ERIC L0 citations52
US8637568B2Jan 28, 2014
Serotonin reuptake inhibitors
STANGELAND ERIC L0 citations52
US8501964B2Aug 6, 2013
Serotonin reuptake inhibitors
STANGELAND ERIC L1 citations52
SAITO DAISUKE ROLAND
7 patentsUS8481563B2Jul 9, 2013
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
SAITO DAISUKE ROLAND7 citations83
US8268863B2Sep 18, 2012
Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
SAITO DAISUKE ROLAND8 citations83
US8163794B2Apr 24, 2012
Crystalline form of a 3-phenoxymethylpyrrolidine compound
SAITO DAISUKE ROLAND7 citations83
US8791151B2Jul 29, 2014
Crystalline form of a 3-phenoxymethylpyrrolidine compound
SAITO DAISUKE ROLAND2 citations62
US9199993B2Dec 1, 2015
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
SAITO DAISUKE ROLAND0 citations51
US9120746B2Sep 1, 2015
Crystalline form of a 3-phenoxymethylpyrrolidine compound
SAITO DAISUKE ROLAND0 citations51
US8802698B2Aug 12, 2014
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
SAITO DAISUKE ROLAND0 citations51
LONG DANIEL D
4 patentsUS9206172B2Dec 8, 2015
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
LONG DANIEL D10 citations92
US8263618B2Sep 11, 2012
8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists
LONG DANIEL D18 citations92
US8518966B2Aug 27, 2013
Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
LONG DANIEL D6 citations83
US8211894B2Jul 3, 2012
Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
LONG DANIEL D2 citations62